Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrrolidine and piperidine modulators of chemokine receptor activity

Pyrrolidine and piperidine modulators of chemokine receptor activity

US Patent 6166037 · Granted Dec 26, 2000

Estimated economic value: $374,629,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses the2025
Dopamine D2 receptor ligands2025
Kinase inhibitors and methods of use thereof2025
Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immuno2024
Fused pentacyclic imidazole derivatives2024
Substituted imidazo[1,2-b]pyridazines and [1,2,4]triazolo[4,3-b]pyridazines as C2023
Inhibitors of histone deacetylase2023
Dopamine D2 receptor ligands2022
Antimalarial hexahydropyrimidine analogues2022
Inhibitors of histone deacetylase2022
Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses the2021
Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors2021